Thus, HDGC is not characterized by the presence of gastric polyposis; it is determined by a complete inactivation of the CDH1 gene, resulting in reduced or even absent expression of E-cadherin, which leads to an increased risk of developing diffuse gastric cancer or lobular breast cancer (3). The gene discussed is CDH1; the disease is hyperplastic polyposis syndrome.